Study on polyglobulia in patients with hemangioblastomas in the CNS regarding EPO levels, tumor size and size of cysts.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006310

Enrollment

Registered

2014-07-10

Start date

2014-07-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D75.1

Interventions

Group 1: Collection of data of all patients with hemangioblatomas where EPO levles were measures between 2009 and 2012. Then collection of data such as: EPO Level, Hb-level, number and size of hemang

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with hemangioblastomas in the CNS of which EPO values are available

Exclusion criteria

Exclusion criteria: THose patients who could have elevated or low HB or EPO levels dur to other causes such as anemia, COPD, smoking, exposure to high altitude.

Design outcomes

Primary

Measure	Time frame
Correlation of polyglobulia with size of solid tumor and size of tumor cysts	—

Secondary

Measure	Time frame
Correlation of polyglobulia and EPO-value	—

Countries

Germany

Contacts

Public ContactMarie Krüger

Klinik für NeurochirurgieUniversitätsklinikum Freiburg

marie.krueger@uniklnik-freiburg.de0761 270 50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 5, 2026